Cancer Registry Software Market
Cancer registries are important tools in research institutes because they make it possible to study the effects of different treatments on various types of cancers and their survival rates. Cancer is one of the most critical diseases of our time and by tracking the disease progression as it occurs and in response to different treatment protocols, researchers have been able to establish important links between cause and effect. A cancer registry software package helps in studying the effect of new drugs on various types of cancers; furthermore, it also helps in tracking the response to treatment in response to new drugs. Cancer registries are useful to patients, families, healthcare workers and research institutes alike.
Global Cancer Registry Software Market: Drivers
High prevalence of cancer is expected to propel growth of the global cancer registry software market over the forecast period. For instance, in 2021, an estimated 281,550 new cases of invasive breast cancer are expected to be diagnosed in women, along with 49,290 new cases of non-invasive (in situ) breast cancer.
Moreover, increasing funding for and adoption of cancer registries is also expected to aid in growth of the market. For instance, over 98% of National Program of Cancer Registries-funded cancer registries used at least one Registry Plus product, by September 2020, according to the U.S. Centers for Disease control and Prevention. Moreover, over half of those used two or more products.
Ask for PDF sample copy of the Cancer Registry Software market report @ https://www.coherentmarketinsights.com/insight/request-pdf/4487
The U.S. is witnessing launch of free cancer registries. For nuance, in March 2020, the Centers for Disease control and Prevention released Registry Plus, a free software suite for collecting and processing cancer registry data that is available to the public.
The market is witnessing launch of new versions of cancer registry software. For instance, in June 2019, the Joint Research Center of European Commission launched the Version 1.8.1 of the JRC – ENCR Cancer Registries Data Quality Check Software. The cancer registry software launched in collaboration with European Network of Cancer Registries offers features such as checking on file formats for incidence, mortality and population of cancer patients and checking of primary multiple malignant tumors.
North America is expected to witness significant growth in the global cancer registry software market, owing to high prevalence of cancer in the region. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Latin America is also expected to witness significant growth in the global cancer registry software market, owing to high prevalence of cancer in the region. For instance, according to Incidência de Câncer no Brasil, the estimated number of new cases of cancer was 600,000, excluding cases of non-melanoma skin cancer during 2018-2019 biennium, in Brazil.
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/4487
Global Cancer Registry Software Market – Competitive Landscape
Major players operating in the global cancer registry software market include, Conduent Inc., CNET Global Solutions, Elekta (Sweden), McKesson Corporation, Ordinal data Inc., Onco Inc., and Rocky Mountain Cancer Data Systems.
Global Cancer Registry Software Market – Taxonomy
By Product Type:
By Deployment Model:
By Database Type:
- Cancer Reporting
- Medical Research
- Patient Care
By End User
- Government Organizations
- Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- North America
- Asia Pacific
- Latin America
- Middle East
Got any Query? Feel free to ask us at: https://www.coherentmarketinsights.com/insight/talk-to-analyst/4487
Table of Content
Global Cancer Registry Software Market Research Report
Section 1: Global Cancer Registry Software Industry Overview
Section 2: Global Economic Impact on Cancer Registry Software Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Cancer Registry Software Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Cancer Registry Software Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027